Niklas Ricklund

Dr. Niklas Ricklund

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2024 in Environment International
Verified
Journal Article
Open access
ZJZheshun Jiang
Zheshun Jiang
RPRomane Person
Romane Person
TLThomas Lundh
Thomas Lundh
DPDaniela Pineda
Daniela Pineda
MEMalin Engfeldt
Malin Engfeldt
KBKarin Broberg
Karin Broberg
Hexavalent chromium (Cr(Ⅵ)) is classified as a group 1 human carcinogen and increases the risk of lung cancer. Non-coding RNAs (ncRNAs) have key regulatory roles in lung cancer, but less is known about their relation to Cr(Ⅵ) exposure. We aimed to 1) measure the expression of lung cancer-related circulating ncRNAs in exposed workers and controls; 2) assess associations between ncRNAs expression and Cr concentrations in red blood cells (RBC) and urine; and 3) evaluate correlations between the ncRNAs. The study included 111 Cr(VI) exposed workers and 72 controls recruited from the SafeChrom project. Cr concentrations were measured in RBC (biomarker of long-term exposure) and urine (biomarker of short-term exposure) samples. Long ncRNA (lncRNA) and microRNA (miRNA) were extracted from plasma followed by deoxyribonuclease treatment, complementary DNA synthesis, and quantitative real-time polymerase chain reaction using target-specific assays for three lncRNAs (H19, MALAT1, NORAD), and four miRNAs (miR-142-3p, miR-15b-5p, miR-3940-5p, miR-451a). Expression levels of lncRNAs MALAT1 and NORAD, and all four miRNAs, were significantly lower in Cr(VI) exposed workers compared with controls, and correlated significantly with RBC-Cr concentrations (rS = -0.16 to -0.38). H19 was non-significantly increased in exposed workers but significantly correlated with miR-142-3p (rS = -0.33) and miR-15b-5p (rS = -0.30), and NORAD was significantly positively correlated with all four miRNAs (rS = 0.17 to 0.46). In multivariate regression models adjusting for confounders, expressions of lncRNAs MALAT1 and NORAD and all miRNAs were still significantly lower in the exposed group compared with controls, and the expression decreased with increasing RBC-Cr concentrations. Cr(VI) exposure was inversely and in a dose-response manner associated with the expression of circulating non-coding RNA, which suggests ncRNAs as potential biomarkers for Cr(VI)-induced toxicity. Correlations between miRNAs and lncRNAs suggest that they participate in the same lncRNA-miRNA-messenger RNA regulatory axes, which may play important roles in Cr(VI) carcinogenesis.

5 December 2023 in International Journal of Hygiene and Environmental Health
Verified
Journal Article
Open access
ZJZheshun Jiang
Zheshun Jiang
LSLinda Schenk
Linda Schenk
EAEva Assarsson
Eva Assarsson
MAMaria Albin
Maria Albin
HBHelen Bertilsson
Helen Bertilsson
MEMalin Engfeldt
Malin Engfeldt
Hexavalent chromium (Cr(VI)) is classified as a human carcinogen. Occupational Cr(VI) exposure can occur during different work processes, but the current exposure to Cr(VI) at Swedish workplaces is unknown. This cross-sectional study (SafeChrom) recruited non-smoking men and women from 14 companies with potential Cr(VI) exposure (n = 113) and controls from 6 companies without Cr(VI) exposure (n = 72). Inhalable Cr(VI) was measured by personal air sampling (outside of respiratory protection) in exposed workers. Total Cr was measured in urine (pre- and post-shift, density-adjusted) and red blood cells (RBC) (reflecting Cr(VI)) in exposed workers and controls. The Bayesian tool Expostats was used to assess risk and evaluate occupational exposure limit (OEL) compliance. The exposed workers performed processing of metal products, steel production, welding, plating, and various chemical processes. The geometric mean concentration of inhalable Cr(VI) in exposed workers was 0.15 μg/m3 (95% confidence interval: 0.11-0.21). Eight of the 113 exposed workers (7%) exceeded the Swedish OEL of 5 μg/m3, and the Bayesian analysis estimated the share of OEL exceedances up to 19.6% for stainless steel welders. Median post-shift urinary (0.60 μg/L, 5th-95th percentile 0.10-3.20) and RBC concentrations (0.73 μg/L, 0.51-2.33) of Cr were significantly higher in the exposed group compared with the controls (urinary 0.10 μg/L, 0.06-0.56 and RBC 0.53 μg/L, 0.42-0.72). Inhalable Cr(VI) correlated with urinary Cr (rS = 0.64) and RBC-Cr (rS = 0.53). Workers within steel production showed the highest concentrations of inhalable, urinary and RBC Cr. Workers with inferred non-acceptable local exhaustion ventilation showed significantly higher inhalable Cr(VI), urinary and RBC Cr concentrations compared with those with inferred acceptable ventilation. Furthermore, workers with inferred correct use of respiratory protection were exposed to significantly higher concentrations of Cr(VI) in air and had higher levels of Cr in urine and RBC than those assessed with incorrect or no use. Based on the Swedish job-exposure-matrix, approximately 17 900 workers were estimated to be occupationally exposed to Cr(VI) today. Our study demonstrates that some workers in Sweden are exposed to high levels of the non-threshold carcinogen Cr(VI). Employers and workers seem aware of Cr(VI) exposure, but more efficient exposure control strategies are required. National strategies aligned with the European strategies are needed in order to eliminate this cause of occupational cancer.

24 November 2022 in Annals of Work Exposures and Health
Verified
Journal Article
Open access
PDF file
NRNiklas Ricklund
Niklas Ricklund
IBIng-Liss Bryngelsson
Ing-Liss Bryngelsson
JHJessika Hagberg
Jessika Hagberg
Working as a professional hairdresser involves the daily usage of many different hair treatment products containing chemicals in complex mixtures. Exposure may induce symptoms in the airways and on the skin. In this study, exposure of hairdressers to volatile organic compounds (VOCs), including aldehydes, was measured in the personal breathing zone in the spring of 2017. The study included 30 hairdressers evenly distributed over ten hair salons in the town of Örebro, Sweden. Work tasks and indoor climate were also surveilled. A hazard index (HI) based on chronic reference values for health was calculated to indicate combined exposure risk. In total, 90 VOCs, including nine aldehydes, were identified. Individual exposure expressed as a total concentration of VOCs (TVOCs) were in the range of 50–3600 µg/m3 toluene equivalent (median 460 µg/m3) and the HI was in the range 0.0046–13 (median 0.9). Exposure was more strongly influenced by variability among hairdressers than among salons. The HI indicated an increased risk of non-carcinogenic effects (HI ≥ 1) at four of the 10 hair salons. Individual working procedures, ventilation, volumetric usage of hair treatment products, certain chemicals in products (formaldehyde, isopropanol, and 2,4- and 2,6-toluene diisocyanate), and availability of reference values may have affected estimates of exposure risks. Nevertheless, the HI may be suitable as a screening tool to assess potential exposure risk posed to hairdressers since it considers the complexity of chemical mixtures and the chronic component of VOC exposure occurring in all indoor environments.

18 August 2023 in BMC Public Health
Verified
Journal Article
Open access
PDF file
NRNiklas Ricklund
Niklas Ricklund
IBIng-Liss Bryngelsson
Ing-Liss Bryngelsson
JHJessika Hagberg
Jessika Hagberg
Background: Working as a hairdresser involves combined exposure to multiple chemicals in hair treatment products that may induce symptoms in airways and skin. Methods: In this cross-sectional study, perceived symptoms among Swedish hairdressers at 10 hair salons were surveyed through a questionnaire. Associations with personal exposure to volatile organic compounds (VOCs), including aldehydes, and their corresponding hazard index (HI), based on the estimated risk for non-cancer health effects, were examined. The prevalence of four out of 11 symptoms was compared to available reference datasets from two other studies of office workers and school staff. Results: All 11 surveyed symptoms were reported among the hairdressers (n = 38). For the whole study group, the most prevalent symptoms were dripping nose (n = 7) and headache (n = 7), followed by eczema (n = 6), stuffed nose (n = 5), cough (n = 5) and discomfort with strong odors (n = 5). Significant relationships between exposure and symptoms were scarce. The exception was total VOC (TVOC) exposure adjusted to worked years in the profession; a difference was observed for any symptom between hairdressers in the group with 20 + years compared to 0–5 years in the profession (logistic regression, OR 0.03, 95% CI 0.001–0.70). Out of the four symptoms available for comparison, the prevalence of headache and cough was significantly higher in hairdressers than in controls (OR 5.18, 95% CI 1.86–13.43 and OR 4.68, 95% CI 1.17–16.07, respectively). Conclusions: Adverse health effects related to occupation was common among the hairdressers, implying a need for exposure control measures in hair salons. Symptoms of headache and cough were more frequently reported by hairdressers than staff in offices and schools. A healthy worker effect among the hairdressers was indicated in the group with 20 + years compared to 0–5 years in the profession. Significant relationships between measured exposure and symptoms were scarce but gave information about advantages and disadvantages of the different exposure measures. The study design could be improved by increasing the size of the study population, using a better match of reference data and increasing the applicability and representability over time of the measured exposure.

1 January 2023 in Annals of Occupational and Environmental Medicine
Verified
Journal Article
Open access
PDF file
JEJohn Ekman
John Ekman
PQPhilip Quartey
Philip Quartey
AUAbdala Mumuni Ussif
Abdala Mumuni Ussif
NRNiklas Ricklund
Niklas Ricklund
DEDaniel Lawer Egbenya
Daniel Lawer Egbenya
FDFrancis Tanam Djankpa
Francis Tanam Djankpa
Ekman J, et al. Ann Occup Environ Med. 2023 Sep;35:e39. https://doi.org/10.35371/aoem.2023.35.e39